teclison.com
Get leads like Teclison — and thousands more
Build targeted lists by tech stack, and more
Teclison: The 11-Person Biotech Betting on Liver Metastasis
How a stealth startup with $0.9M revenue is tackling cancer's deadliest frontier
In a biotech landscape dominated by billion-dollar pharma giants, Teclison is playing a different game: targeting liver metastasis with a lean team of 11 and a mission to transform immunotherapy from the ground up.
"Teclison isn't building a better drug—they're building a smarter way to attack the most stubborn metastases."
The Liver Metastasis Problem
Liver metastasis is where cancers go to survive. The liver's unique immune environment suppresses standard therapies, making it a deadly fortress. Teclison's approach focuses on inducing tumor necrosis while enhancing antitumor immunity—essentially turning the body's defense system into a precision weapon against these resistant sites. This isn't incremental improvement; it's a fundamental rethinking of how to attack metastatic cancer.
The Lean Biotech Model
With just 11 employees and $0.9M in revenue, Teclison operates like a tech startup, not a traditional biotech. Their use of modern web stack (Next.js, Tailwind) suggests a digital-first mindset that likely extends to their R&D. This isn't a company burning cash on flashy offices—they're focused entirely on clinical innovation. The founder wears three hats (CEO, CMO, Founder), indicating deep technical leadership with minimal bureaucracy.
What makes Teclison fascinating is their positioning. They're not chasing the crowded PD-1/PD-L1 market. Instead, they're targeting a specific, high-mortality niche: liver metastasis. This focus allows them to build expertise while avoiding direct competition with pharma behemoths. Their lack of public funding data suggests they're either pre-revenue clinical stage or intentionally flying under the radar—a common strategy for biotechs protecting IP.
- Single-founder led with deep medical expertise (CMO background)
- Modern web infrastructure suggests digital-native operations
- Revenue-generating despite early-stage appearance ($0.9M)
- Privacy-first approach with no public social profiles
The Under-the-Radar Disruptor
Teclison represents a new breed of biotech: small, focused, and digitally-native. While they lack scale, their surgical precision on liver metastasis could unlock massive value if clinical data validates their approach. For investors, this is either a stealth opportunity or a high-risk bet—there's no middle ground.
What tech stack does Teclison use?
How much traffic does Teclison get?
Traffic & Engagement
How is Teclison's SEO?
Open Graph Image
https://storage.googleapis.com/teclison/teclison_og_image.webp
Meta Tags
Teclison | Transforming cancer treatment by enhancing immunotherapy
At Teclison, we develop innovative cancer therapies to induce tumor necrosis and enhance antitumor immunity, offering patients with liver metastasis the hope of longer, better lives.
Transforming cancer treatment by enhancing immunotherapy. At Teclison, we develop innovative cancer therapies to induce tumor necrosis and enhance antitumor immunity, offering patients with liver metastasis the hope of longer, better lives.
H1 Tags
What is Teclison's revenue?
Who works at Teclison?
Loading leads...
What do customers think of Teclison?
No Trustpilot reviews available for this company.
Frequently Asked Questions about Teclison
What is Teclison's Revenue?
What does Teclison do?
How fast is Teclison growing?
What technologies does Teclison use?
Who are Teclison's competitors?
Export Data
Unlock all exports
Download CSVs, JSONs & full reports
How to contact Teclison?
Contact Information
Export teclison.com Data
Download the complete tech stack, analytics, leads, and company data for teclison.com in JSON or CSV format. Use it for your sales pipeline, competitive analysis, or research.
Raw JSON Data
Click "Show" to view the raw API response data
About teclison.com
At Teclison, we develop innovative cancer therapies to induce tumor necrosis and enhance antitumor immunity, offering patients with liver metastasis the hope of longer, better lives.
Company Overview
Contact teclison.com
Email Addresses
Technology Stack
teclison.com uses 11 technologies across their website including HSTS, WordPress, Vercel, and more.
Security
HSTS
CMS
WordPress
Cloud & Hosting
Vercel
Performance
Lazy Loading, Priority Hints
Web Standards
Twitter Cards
UI Libraries
DaisyUI, Radix UI
Traffic & Audience
teclison.com receives approximately 0 monthly visitors. The website has a bounce rate of 0% with visitors viewing an average of 0.0 pages per visit. Users spend an average of 0:00 on the site.
Frequently Asked Questions
What is teclison.com?
What technologies does teclison.com use?
How do I contact teclison.com?
Is teclison.com hiring?
How popular is teclison.com?
Related Searches
This page provides publicly available information about teclison.com. Data is collected from various public sources and may not always be up to date. For the most accurate information, please visit teclison.com directly at https://teclison.com.